The FDA approves the first ever postpartum depression product. Positive results from Dermira’s atopic dermatitis product Lebrikizumab
March 20, 2019
0
News We Loved to Hear The First and Only Approval of a Specific Product for Postpartum Depression The FDA granted approval of Sage Therapeutics’ (SAGE) ZULRESSOTM (brexanolone) injection. A product for the treatment of the condition known as postpartum depression (PPD). Zulresso became the first and only medicine specifically approved to treat PPD; the most common medical complication of childbirth. The product …
